Variant report
Variant | nsv516906 |
---|---|
Chromosome Location | chr9:25913301-25919851 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372649919 | chr9:25914805-25914806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs118052712 | chr9:25914806-25914807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565186257 | chr9:25914875-25914876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577378671 | chr9:25914876-25914877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544780470 | chr9:25914907-25914908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563193717 | chr9:25914909-25914910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7032063 | chr9:25914919-25914920 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs548882780 | chr9:25914932-25914933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560987987 | chr9:25914947-25914948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370959120 | chr9:25914952-25914953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181868728 | chr9:25914970-25914971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76228747 | chr9:25914996-25914997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10812323 | chr9:25915444-25915445 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560584841 | chr9:25915475-25915476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115719952 | chr9:25915484-25915485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573014101 | chr9:25915487-25915488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546254125 | chr9:25915514-25915515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148591401 | chr9:25915533-25915534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532110086 | chr9:25915535-25915536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550253868 | chr9:25915551-25915552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138617297 | chr9:25917024-25917025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530153074 | chr9:25917035-25917036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183625780 | chr9:25917065-25917066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188134189 | chr9:25917080-25917081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373720507 | chr9:25917126-25917127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567369049 | chr9:25917153-25917154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192751665 | chr9:25917203-25917204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148906226 | chr9:25917231-25917232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143547414 | chr9:25917261-25917262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560144530 | chr9:25917283-25917284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572164567 | chr9:25917364-25917365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79808111 | chr9:25917386-25917387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs59885701 | chr9:25917428-25917429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375011060 | chr9:25917432-25917433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564253916 | chr9:25917447-25917448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531673597 | chr9:25917458-25917459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550090062 | chr9:25917472-25917473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529628100 | chr9:25917473-25917474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529241266 | chr9:25917511-25917512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs114533272 | chr9:25917528-25917529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138158408 | chr9:25917582-25917583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539665725 | chr9:25917603-25917604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551586674 | chr9:25917651-25917652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569899672 | chr9:25917654-25917655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1219938 | chr9:25917668-25917669 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs528693136 | chr9:25917691-25917692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs60181404 | chr9:25917704-25917705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs80117548 | chr9:25917756-25917757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550930055 | chr9:25917771-25917772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375413130 | chr9:25917786-25917787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
polycythaemia | 22829968 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:25914800-25915000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr9:25915400-25915600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr9:25917000-25918800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr9:25917200-25918200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr9:25917400-25919000 | Enhancers | Hela-S3 | cervix |
6 | chr9:25917600-25918200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr9:25917600-25918800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr9:25917600-25919000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr9:25917600-25919400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr9:25917800-25918200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr9:25918000-25918400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr9:25918200-25923200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |